Msn - Profile
✉ Email this page to a colleague
Drugs and US Patents for Msn
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Msn | ROFLUMILAST | roflumilast | TABLET;ORAL | 208256-002 | Sep 7, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 217399-001 | Jan 18, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn Pharms Inc | DROXIDOPA | droxidopa | CAPSULE;ORAL | 211741-001 | Feb 18, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | LURASIDONE HYDROCHLORIDE | lurasidone hydrochloride | TABLET;ORAL | 208037-005 | Sep 9, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | LEVETIRACETAM | levetiracetam | TABLET;ORAL | 214815-003 | Oct 7, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |